Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-muscle-Invasive Bladder Cancer.

Thorsten H Ecke,Natalya Benderska-Söder,Ekkehardt Bismarck,Bas W G van Rhijn,Tilman Todenhöfer,Bernd J Schmitz-Dräger

Methods in molecular biology (Clifton, N.J.)（2023）

引用 0|浏览1

暂无评分

摘要

Based on the results of this simulation, a marker-supported follow-up of patients with high-risk (HR) NMIBC is safe and offers options to significantly reduce the number of cystoscopies without compromising the Se. Further research focusing on prospective randomized trials is needed to finally find a way to include marker results into clinical decision-making.

查看译文

关键词

bladder cancer,biomarker,urine,point-of-care,high-risk,non-muscle-invasive

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要